Hims & Hers raised its full-year revenue guidance to $3.3 billion despite reporting a wider-than-expected second-quarter loss of $0.37 per share. While Q2 revenue grew 38% year-over-year to $753.21 million, the company struggled with declining gross margins and rising operating expenses. Furthermore, the telehealth platform is currently facing an FTC lawsuit regarding allegations of deceptive billing practices and the unauthorized sharing of sensitive health data.
